Skip to main content

Pathogen and Graphene

Objectif

Complications related to infectious diseases have significantly reduced, particularly in the developed countries, due to the availability and use of broad-range antibiotics and wide variety of antimicrobial agents. Excessive use of antibiotics and antimicrobial agents increased significantly the number of multi-drug resistant (MDR) bacteria. This has resulted in a serious threat to public health. The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the low rate of emergence of new clinically useful antibiotics, has refocused attention on finding alternatives to overcome antimicrobial resistance. Novel strategies aiming to reduce the amount of antibiotics, but able to prevent and treat animal and human infections should be investigated, evidenced and approved. Among the various approaches, the use of graphene and its derivatives is currently considered a highly promising strategy to overcome microbial drug resistance.

In line with this interest in graphene by the European Commission through the graphene ‘flagship’ initiatives, we respond in this consortium by exploring the utility of novel graphene based nanocomposites for the management and better understanding of microbial infections. The anti-microbical potential of the novel graphene based nanomaterials, the possibility of using such structures for the development of non-invase therapies together with the understanding of the mechanism of action will be the main focal points of the proposed project entitled “PANG”, relating to Pathogen and Graphene.

We have gathered the essential elements, namely different academic institutions in Europe (France, Germany, and Sweden) and their associated countries (Ukraine) as well as two European companies (Graphenea-Spain and LSO Medical-France) and one company (RS RESEARCH) in one of the associated countries (Turkey). The proposed multidisciplinary project uniquely suits high-level interdisciplinary and cross-border training.

Appel à propositions

H2020-MSCA-RISE-2015
Voir d’autres projets de cet appel

Coordinateur

UNIVERSITE DE LILLE
Adresse
42 Rue Paul Duez
59800 Lille
France
Type d’activité
Higher or Secondary Education Establishments
Contribution de l’UE
€ 108 000

Participants (7)

RUHR-UNIVERSITAET BOCHUM
Allemagne
Contribution de l’UE
€ 72 000
Adresse
Universitaetsstrasse 150
44801 Bochum
Type d’activité
Higher or Secondary Education Establishments
UNIVERSITATSKLINIKUM ERLANGEN
Allemagne
Contribution de l’UE
€ 45 000
Adresse
Maximiliansplatz 2
91054 Erlangen
Type d’activité
Higher or Secondary Education Establishments
GOETEBORGS UNIVERSITET
Suède
Contribution de l’UE
€ 22 500
Adresse
Vasaparken
405 30 Goeteborg
Type d’activité
Higher or Secondary Education Establishments
LVIVSKYI NATIONALNYI MEDYCHNYI UNIVERSYTET IMENI DANYLA HALYTSKOHO
Ukraine
Contribution de l’UE
€ 76 500
Adresse
69 Pekarska Street
79010 Lviv
Type d’activité
Higher or Secondary Education Establishments
GRAPHENEA SA
Espagne
Contribution de l’UE
€ 49 500
Adresse
Paseo Mikeletegi 83
20009 San Sebastian Guipuzcoa
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
LSO MEDICAL
France
Contribution de l’UE
€ 49 500
Adresse
280 Rue Salvador Allende
59120 Loos
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM SIRKETI
Turquie
Contribution de l’UE
€ 157 500
Adresse
Sanayi Mah Teknopark Blv. Teknopark 2A Apt No 1/2A
34906 Istanbul
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)